Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Adherium Ltd. ( (AU:ADR) ) has shared an announcement.
Adherium Limited has announced a successful capital raise of $900,000 through the issuance of convertible notes, supported by Phillip Asset Management Limited and Trudell Medical Limited. The funds will be used to further the roll-out of the Hailie® Smartinhaler® platform in the U.S. and for general working capital, potentially strengthening Adherium’s market position in digital health solutions for respiratory care.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in the development and distribution of the Hailie® Smartinhaler® platform. The company focuses on enhancing respiratory medication adherence through its innovative technology, primarily targeting the United States market.
Average Trading Volume: 1,371,430
Technical Sentiment Signal: Sell
Current Market Cap: A$6.07M
See more insights into ADR stock on TipRanks’ Stock Analysis page.